Peptides in Europe
Import rules, legality and availability, by region
There is no single European rule. Personal importation of medicines is governed by national law, and neighbouring countries reach opposite answers — Denmark opened third-country postal imports in January 2026; Norway prohibits prescription medicines by post from everywhere, including from Denmark. These guides cover what is lawful, what the penalties are, and what is actually reimbursed.
By region
Regional guides
- NordicsDenmark opened third-country postal imports in January 2026. Norway, next door, bans prescription medicines by post from everywhere.Sweden · Denmark · Norway · Finland · Iceland
- BalticsLithuania allows ten packages a month from outside the EU. Estonia bans postal delivery of internet-ordered medicines entirely. Latvia caps growth hormone at fourteen days.Estonia · Latvia · Lithuania
- BeneluxBelgium restricted who may prescribe a GLP-1 by Royal Decree — an instrument with no equivalent elsewhere in Europe.Netherlands · Belgium · Luxembourg
- Central & Eastern EuropeRomania punishes import with two to seven years, harsher than trafficking. Czechia criminalises possession above a single vial.Poland · Czechia · Hungary · Slovakia · Slovenia · Croatia · Romania · Bulgaria · Greece
- DACH — in progressSwitzerland sits outside both the EU and the EEA, which changes the regulatory route entirely.Germany · Austria · Switzerland
- Iberia — in progressSpain and Portugal diverge on personal import despite near-identical EU obligations.Spain · Portugal
Regions marked in progress are researched but not yet published. We hold a guide back rather than publish legal information we have not been able to verify against a primary source.
EU-wide
Availability and sourcing across the bloc
Regulatory
Legal status
For the bloc-level regulatory position see the European Union legal guide, and for the full picture across jurisdictions the legal status index and the legal status cornerstone.